journal article·2020-07-08

Ultra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells

Chenyi An, Wei Hu, Jie Gao, Bing-Feng Ju, Peyman Obeidy, Yunduo Charles Zhao, Xiaoxuan Tu, Weijia Fang, Lining Arnold Ju, Wei Chen

Nano Letters· Volume 20· Issue 7
Publisher page

Abstract

Immune checkpoint blockade with monoclonal antibodies (mAbs) that target programmed cell death protein-1 (PD-1) has remarkably revolutionized cancer therapy. Their binding kinetics measured by surface plasmon resonance does not always correlate well with their immunotherapeutic efficacies, mainly due to the lack of two-dimensional cell plasma membrane and the capability of force sensing and manipulation. In this regard, based on a more suitable and ultra-sensitive biomechanical nanotool, biomembrane force probe (BFP), we developed a Double-edge Smart Feedback control system as an ultra-stable platform to characterize ultra-long bond lifetimes of receptor-ligand binding on living cells. We further benchmarked the dissociation kinetics for three clinically approved PD-1 blockade mAbs (Nivolumab, Pembrolizumab, and Camrelizumab), intriguingly correlating well with the objective response rates in the hepatocellular carcinoma second-line treatment. This ultra-stable BFP potentially provides a compelling kinetic platform to direct the screening, optimization, and clinical selection of therapeutic antibodies in the future.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Force Microscopy Techniques and Applications · thermodynamics and calorimetric analyses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cell Biology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Fluid Power and Mechatronic Systems, Key Laboratory for Biomedical Engineering of Ministry of Education, and School of Mechanical Engineering, Zhejiang University, Hangzhou, China, 310058

School of Biomedical Engineering, Faculty of Engineering and Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales Australia, 2006

Department of Medical Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310000

Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 310000

Heart Research Institute, Newtown, New South Wales Australia, 2042

State Key Laboratory for Modern Optical Instrumentation and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, China, 310058

Funding

National Basic Research Program of China · Fundamental Research Funds for the Central Universities · Australian Research Council DECRA · Australian Research Council Discovery Project · NSW Cardiovascular Capacity Building Program (Early-Mid Career Research Grant) · University of Sydney Faculty of Engineering Major Equipment Scheme · National Science Foundation of China · National Heart Foundation Future Leader · Sydney Research Accelerator prize (SOAR)

References (35)

Show source-provided references
1. 10.1038/nrc323910.1038/nrc3239 ↗
2. 10.1007/s00216-018-1008-810.1007/s00216-018-1008-8 ↗
3. 10.1038/nbt0505-55610.1038/nbt0505-556 ↗
4. 10.1038/nature0894410.1038/nature08944 ↗
5. 10.1038/nchem.143410.1038/nchem.1434 ↗
6. 10.1021/acs.analchem.5b0257210.1021/acs.analchem.5b02572 ↗
7. 10.1126/scitranslmed.aal360410.1126/scitranslmed.aal3604 ↗
8. 10.1073/pnas.190403411610.1073/pnas.1904034116 ↗
9. 10.1007/s00262-018-2160-x10.1007/s00262-018-2160-x ↗
10. 10.1016/j.cbpa.2019.08.00510.1016/j.cbpa.2019.08.005 ↗
11. 10.1146/annurev-physchem-040214-12174210.1146/annurev-physchem-040214-121742 ↗
12. 10.1007/s12551-018-0447-y10.1007/s12551-018-0447-y ↗
13. 10.1016/j.molcel.2018.12.01810.1016/j.molcel.2018.12.018 ↗
14. 10.1038/1621910.1038/16219 ↗
15. 10.1083/jcb.20060605610.1083/jcb.200606056 ↗
16. 10.1016/j.cell.2014.02.05310.1016/j.cell.2014.02.053 ↗
17. 10.7554/eLife.1544710.7554/eLife.15447 ↗
18. 10.1038/s41563-019-0323-610.1038/s41563-019-0323-6 ↗
19. 10.1074/jbc.M110.15577010.1074/jbc.M110.155770 ↗
20. 10.1093/annonc/mdy424.02910.1093/annonc/mdy424.029 ↗
21. 10.1016/S1470-2045(18)30351-610.1016/S1470-2045(18)30351-6 ↗
22. 10.1016/S0140-6736(17)31046-210.1016/S0140-6736(17)31046-2 ↗
23. 10.1080/19420862.2019.159651410.1080/19420862.2019.1596514 ↗
24. Wang, M.; Wang, J.; Wang, R.; Jiao, S.; Wang, S.; Zhang, J.; Zhang, M. Identification of a Monoclonal Antibody That Targets PD-1 in a Manner Requiring PD-1 Asn58 Glycosylation. Commun. Biol. 2019, 2.10.1038/s42003-019-0642-9 ↗
25. 10.1529/biophysj.107.11789510.1529/biophysj.107.117895 ↗
26. 10.1016/j.ab.2016.06.02410.1016/j.ab.2016.06.024 ↗
27. 10.1091/mbc.e17-04-022810.1091/mbc.e17-04-0228 ↗
28. 10.1126/science.34757510.1126/science.347575 ↗
29. 10.1038/nprot.2013.05610.1038/nprot.2013.056 ↗
30. 10.1073/pnas.98.2.46810.1073/pnas.98.2.468 ↗
31. 10.1063/1.294033910.1063/1.2940339 ↗
32. 10.1146/annurev.cellbio.17.1.13310.1146/annurev.cellbio.17.1.133 ↗
33. 10.1074/jbc.M40703920010.1074/jbc.M407039200 ↗
34. 10.7554/eLife.4668910.7554/eLife.46689 ↗
35. 10.1074/jbc.M113.50400110.1074/jbc.M113.504001 ↗